Osteotriol (Calcitriol)

Calcitriol, the active ingredient in Osteotriol, is a vitamin D analog presented as a strength/form for oral use. It helps regulate calcium metabolism and supports bone health in patients with conditions such as renal osteodystrophy and hypocalcemia. GNH USA supplies Osteotriol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Osteotriol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

Osteotriol is a vitamin‑D‑type analogue that acts on calcium‑phosphate metabolism pathways.

- Renal osteodystrophy: improves calcium absorption and helps normalize bone turnover. - Secondary hyperparathyroidism: reduces parathyroid hormone levels associated with chronic kidney disease. - Hypocalcemia: raises serum calcium concentrations in patients with low calcium levels. - Osteoporosis prevention: supports bone mineral density when used with other osteoporosis therapies.

Calcitriol may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Hyper‑hyper   -   -  -  -  - 

Serious or Rare Side Effects: -  - 

Osteotriol should be monitored for calcium‑related safety concerns.

- Monitor  -  -  -  -  - Store